Search
for
Sort by
Research 481–510 of 1000+
- Baricitinib in Dermatology: Expanding Therapeutic Horizons Beyond Alopecia Areata
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- BH09 Patient experience of off-label Janus kinase inhibitor use for alopecia areata in a cohort of 34 patients from a single UK practitioner: exploring changing trends in healthcare provision and access to drug treatments
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Differences in activation of β-catenin in outer root sheath cells between the type of JAK inhibitor: An alternative mechanism promoting hair growth by JAK inhibitors in alopecia areata
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials
- Efficacy and Safety of Switching from Baricitinib to Ritlecitinib in Severe Alopecia Areata
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- P123 : Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and metaanalysis
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- 75360 Nasal hair (vibrissae) involvement in patients with alopecia areata universalis: preliminary results showing density modification and response to oral JAK inhibitors
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- 73192 Consistent Efficacy of Upadacitinib in Alopecia Areata Subgroups: Adult, Pediatric, Severe Disease, and JAK-Refractory Patients — A Meta-Analysis
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Иммунологические аспекты гнездной алопеции: от патогенеза к терапевтическим стратегиям
- What is the appropriate indication for baricitinib in patients with alopecia areata? What prior options can be considered?
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Janus Kinase inhibitors in dermatology: a review
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases